T21	Exp 429 434	which
T22	Exp 454 466	the long arm
T23	Exp 518 522	that
T24	Exp 484 498	The expression
T25	Exp 502 516	the M-CSF gene
T26	Exp 555 568	the short arm
T27	Exp 622 631	the study
T28	Exp 651 664	the potential
T29	Exp 673 687	the expression
T30	Exp 706 721	the maintenance
T31	Exp 739 760	the neoplastic clones
T32	Exp 860 877	the second allele
T33	Exp 881 895	the same genes
T34	Exp 899 917	the leukemic cells
T35	Exp 691 702	these genes
T36	Exp 919 935	The latter issue
T37	Exp 1047 1062	the 17 patients
T38	Exp 1088 1102	The M-CSF gene
T39	Exp 1132 1139	the FMS
T40	Exp 1144 1159	the EGR-1 genes
T41	Exp 1183 1199	the latter cases
T42	Exp 1265 1279	the 2 patients
T43	Exp 1307 1316	the M-CSF
T44	Exp 1394 1403	the genes
R4	Coref Anaphora:T21 Antecedent:T45
R5	Coref Anaphora:T23 Antecedent:T25
T46	SPAN 409 422	FMS and EGR-1
R6	Coref Anaphora:T35 Antecedent:T46
T47	SPAN 409 422	FMS and EGR-1
R7	Coref Anaphora:T33 Antecedent:T47
T1	Protein 40 46	GM-CSF
T2	Protein 48 52	IL-3
T3	Protein 54 68	M-CSF receptor
T4	Protein 70 75	C-FMS
T5	Protein 78 106	early growth response gene-1
T6	Protein 108 113	EGR-1
T7	Protein 119 124	M-CSF
T8	Protein 395 399	IL-3
T9	Protein 401 407	GM-CSF
T10	Protein 409 412	FMS
T11	Protein 417 422	EGR-1
T12	Protein 506 511	M-CSF
T13	Protein 1092 1097	M-CSF
T14	Protein 1136 1139	FMS
T15	Protein 1148 1153	EGR-1
T16	Protein 1311 1316	M-CSF
T17	Protein 1321 1324	FMS
T45	Exp 423 428	genes
